Effect of panaxytriol on cytochrome P450 3A4 via the pregnane X receptor regulatory pathway.


Journal

Phytotherapy research : PTR
ISSN: 1099-1573
Titre abrégé: Phytother Res
Pays: England
ID NLM: 8904486

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 14 08 2018
revised: 17 12 2018
accepted: 20 12 2018
pubmed: 18 1 2019
medline: 14 6 2019
entrez: 18 1 2019
Statut: ppublish

Résumé

Panaxytriol (PXT) is one of the major effective components of red ginseng and Shenmai injection. The present study aimed to explore the effect of PXT on cytochrome P450 3A4 (CYP3A4) based on the pregnane X receptor (PXR)-CYP3A4 regulatory pathway in HepG2 cells and hPXR-overexpressing HepG2 cells treated with PXT for different time periods using quantitative polymerase chain reaction, Western blot, and dual-luciferase reporter gene assays. PXT could upregulate the levels of PXR and CYP3A4 mRNA in HepG2 cells treated with PXT for 1 hr, with no impact on the expression of their protein levels. The expression levels of both PXR and CYP3A4 mRNA and protein in HepG2 cells treated with PXT for 24 hr increased in a concentration-dependent manner. The effects of PXT on the expression of PXR and CYP3A4 mRNA and protein in hPXR-overexpressing HepG2 cells were similar to those in HepG2 cells. Moreover, the influence trend of PXT on CYP3A4 was consistent with that of PXR in HepG2 cells and hPXR-overexpressing HepG2 cells. The dual-luciferase reporter gene assay in HepG2 cells further demonstrated that PXT treatment for specific time periods could significantly induce the expression of CYP3A4 mediated by the PXR regulatory pathway.

Identifiants

pubmed: 30653754
doi: 10.1002/ptr.6290
doi:

Substances chimiques

Drug Combinations 0
Drugs, Chinese Herbal 0
Enediynes 0
Fatty Alcohols 0
Pregnane X Receptor 0
Receptors, Steroid 0
fructus schizandrae, radix ginseng, radix ophiopogonis drug combination 0
panaxytriol 87005-03-6
Cytochrome P-450 CYP3A EC 1.14.14.1
CYP3A4 protein, human EC 1.14.14.55

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

968-975

Subventions

Organisme : China National Nature Science Fund
ID : 81560606 and 81760672

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Jie Wu (J)

Clinical Pharmacology Institute, Nanchang University, Nanchang, China.
School of Pharmaceutical Engineering, Chongqing Chemical Industry Vocational College, Chongqing, China.

Na Yao (N)

Clinical Pharmacology Institute, Nanchang University, Nanchang, China.

Qingqing Hu (Q)

Clinical Pharmacology Institute, Nanchang University, Nanchang, China.

Mingyi Liu (M)

Clinical Pharmacology Institute, Nanchang University, Nanchang, China.

Hong Zhang (H)

Clinical Pharmacology Institute, Nanchang University, Nanchang, China.

Yuqing Xiong (Y)

Clinical Pharmacology Institute, Nanchang University, Nanchang, China.

Jinfang Hu (J)

Drug Clinical Research Center, The First Affiliated Hospital of Nanchang University, Nanchang, China.

Chunhua Xia (C)

Clinical Pharmacology Institute, Nanchang University, Nanchang, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH